Lu Li
Stock Analyst at UBS
(2.39)
# 3,177
Out of 4,604 analysts
26
Total ratings
80%
Success rate
5.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QDEL QuidelOrtho | Rated: Hold | $17 → $12 | $17.50 | -31.41% | 7 | May 7, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $375 | $400.00 | -6.25% | 2 | May 6, 2026 | |
| VCYT Veracyte | Maintained: Buy | $48 → $52 | $46.15 | +12.68% | 6 | May 6, 2026 | |
| DHR Danaher | Maintained: Buy | $250 | $199.66 | +25.21% | 1 | Apr 22, 2026 | |
| FLGT Fulgent Genetics | Maintained: Buy | $35 → $22 | $18.53 | +18.73% | 3 | Mar 2, 2026 | |
| MYGN Myriad Genetics | Maintained: Hold | $8 → $6 | $3.15 | +90.48% | 7 | Feb 25, 2026 |
QuidelOrtho
May 7, 2026
Rated: Hold
Price Target: $17 → $12
Current: $17.50
Upside: -31.41%
Waters
May 6, 2026
Maintained: Hold
Price Target: $330 → $375
Current: $400.00
Upside: -6.25%
Veracyte
May 6, 2026
Maintained: Buy
Price Target: $48 → $52
Current: $46.15
Upside: +12.68%
Danaher
Apr 22, 2026
Maintained: Buy
Price Target: $250
Current: $199.66
Upside: +25.21%
Fulgent Genetics
Mar 2, 2026
Maintained: Buy
Price Target: $35 → $22
Current: $18.53
Upside: +18.73%
Myriad Genetics
Feb 25, 2026
Maintained: Hold
Price Target: $8 → $6
Current: $3.15
Upside: +90.48%